The Placenta as a Functional Barrier to Fetal Drug Exposure

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)
Original languageEnglish (US)
Title of host publicationThe Placenta: From Development to Disease
PublisherWiley-Blackwell
Pages303-309
Number of pages7
ISBN (Print)9781444333664
DOIs
StatePublished - Mar 21 2011

Fingerprint

Neonatal Abstinence Syndrome
Opioid-Related Disorders
Placenta
Single Nucleotide Polymorphism
Pharmaceutical Preparations

Keywords

  • "kick the habit"
  • "permeability barrier"
  • Breast Cancer Resistance Protein (BCRP)
  • Inside-out vesicles (IOV)
  • Neonatal abstinence syndrome (NAS)
  • Nicotine addiction
  • Nicotine replacement therapy (NRTs)
  • Opiate dependence and addiction
  • Single nucleotide polymorphisms (SNPs)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nanovskaya, T., Hankins, G., & Ahmed, M. (2011). The Placenta as a Functional Barrier to Fetal Drug Exposure. In The Placenta: From Development to Disease (pp. 303-309). Wiley-Blackwell. https://doi.org/10.1002/9781444393927.ch39

The Placenta as a Functional Barrier to Fetal Drug Exposure. / Nanovskaya, Tatiana; Hankins, Gary; Ahmed, Mahmoud.

The Placenta: From Development to Disease. Wiley-Blackwell, 2011. p. 303-309.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nanovskaya, T, Hankins, G & Ahmed, M 2011, The Placenta as a Functional Barrier to Fetal Drug Exposure. in The Placenta: From Development to Disease. Wiley-Blackwell, pp. 303-309. https://doi.org/10.1002/9781444393927.ch39
Nanovskaya T, Hankins G, Ahmed M. The Placenta as a Functional Barrier to Fetal Drug Exposure. In The Placenta: From Development to Disease. Wiley-Blackwell. 2011. p. 303-309 https://doi.org/10.1002/9781444393927.ch39
Nanovskaya, Tatiana ; Hankins, Gary ; Ahmed, Mahmoud. / The Placenta as a Functional Barrier to Fetal Drug Exposure. The Placenta: From Development to Disease. Wiley-Blackwell, 2011. pp. 303-309
@inbook{fcd5cac9a1d641c0bcfb4870dd469a08,
title = "The Placenta as a Functional Barrier to Fetal Drug Exposure",
keywords = "{"}kick the habit{"}, {"}permeability barrier{"}, Breast Cancer Resistance Protein (BCRP), Inside-out vesicles (IOV), Neonatal abstinence syndrome (NAS), Nicotine addiction, Nicotine replacement therapy (NRTs), Opiate dependence and addiction, Single nucleotide polymorphisms (SNPs)",
author = "Tatiana Nanovskaya and Gary Hankins and Mahmoud Ahmed",
year = "2011",
month = "3",
day = "21",
doi = "10.1002/9781444393927.ch39",
language = "English (US)",
isbn = "9781444333664",
pages = "303--309",
booktitle = "The Placenta: From Development to Disease",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - The Placenta as a Functional Barrier to Fetal Drug Exposure

AU - Nanovskaya, Tatiana

AU - Hankins, Gary

AU - Ahmed, Mahmoud

PY - 2011/3/21

Y1 - 2011/3/21

KW - "kick the habit"

KW - "permeability barrier"

KW - Breast Cancer Resistance Protein (BCRP)

KW - Inside-out vesicles (IOV)

KW - Neonatal abstinence syndrome (NAS)

KW - Nicotine addiction

KW - Nicotine replacement therapy (NRTs)

KW - Opiate dependence and addiction

KW - Single nucleotide polymorphisms (SNPs)

UR - http://www.scopus.com/inward/record.url?scp=84885540192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885540192&partnerID=8YFLogxK

U2 - 10.1002/9781444393927.ch39

DO - 10.1002/9781444393927.ch39

M3 - Chapter

AN - SCOPUS:84885540192

SN - 9781444333664

SP - 303

EP - 309

BT - The Placenta: From Development to Disease

PB - Wiley-Blackwell

ER -